Cardiology Devices - Southern Asia

The projected revenue in the Cardiology Devices market market in Southern Asia is expected to reach US$1.28bn in 2025.
This indicates a promising growth potential for the industry in this region.
Furthermore, it is anticipated that the market will experience a steady annual growth rate of 8.68% from 2025 to 2029, resulting in a market volume of US$1.78bn by 2029.
It is worth noting that in a global comparison, the United States is expected to generate the highest revenue in the Cardiology Devices market market, amounting to US$27.42bn in 2025.
This highlights the significant market presence and dominance of the United States in this sector.
In Southern Asia, the demand for advanced cardiology devices is rapidly growing, with an emphasis on innovative and cost-effective solutions.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Cardiology diagnostic & monitoring devices
Cardiology surgical devices
Implants such as pacemakers

Cardiology drugs
Cardiology supplements

Medical Devices: market data & analysis

Cardiology Devices market in Southern Asia is experiencing significant growth due to several factors.

Customer preferences: Customers in Southern Asia have shown a growing preference for advanced cardiology devices that offer accurate diagnosis and effective treatment options. They are increasingly seeking devices that are minimally invasive, provide real-time monitoring, and are compatible with digital healthcare systems. This preference is driven by the desire for quicker recovery, reduced hospital stays, and improved quality of life. Additionally, customers in this region are becoming more aware of cardiovascular health and are actively seeking preventive measures and early detection of heart diseases.

Trends in the market: One of the key trends in the Cardiology Devices market in Southern Asia is the adoption of innovative technologies. Advanced devices such as implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), and transcatheter heart valves are gaining popularity in the region. These devices offer improved patient outcomes, reduced risks, and enhanced precision in diagnosis and treatment. Moreover, there is a growing trend towards the use of remote monitoring systems, allowing healthcare professionals to track patients' cardiac health remotely and provide timely interventions. Another trend in the market is the increasing demand for interventional cardiology devices. Southern Asia is witnessing a rise in the number of interventional procedures such as angioplasty and stenting, driven by the increasing prevalence of cardiovascular diseases. This has led to a higher demand for devices such as coronary stents, catheters, and guidewires. These devices enable minimally invasive procedures, resulting in shorter recovery times and reduced healthcare costs.

Local special circumstances: Southern Asia is home to a large population, and the region is experiencing a demographic shift with an aging population and a rise in non-communicable diseases, including cardiovascular diseases. This demographic change is driving the demand for cardiology devices as the healthcare system strives to meet the growing needs of the population. Additionally, the region has witnessed an increase in healthcare expenditure and improvements in healthcare infrastructure, further contributing to the growth of the cardiology devices market.

Underlying macroeconomic factors: The economic growth in Southern Asia, coupled with rising disposable incomes, has resulted in increased healthcare spending. This has enabled individuals to afford advanced cardiology devices and treatments, driving the market growth. Furthermore, favorable government initiatives and policies aimed at improving healthcare access and quality have also played a crucial role in the development of the cardiology devices market in the region. These factors, combined with the increasing prevalence of cardiovascular diseases, have created a conducive environment for the growth of the cardiology devices market in Southern Asia.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.

Cardiology Devices - Southern Asia

Revenue

Key Players

Analyst Opinion

Global Comparison

Methodology

Health

Access more Market Insights on Health topics with our featured report

Key Market Indicators

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Contact